US2021290119A1PendingUtilityA1

Analyte sensor

Assignee: DEXCOM INCPriority: Jul 13, 2004Filed: Jun 7, 2021Published: Sep 23, 2021
Est. expiryJul 13, 2024(expired)· nominal 20-yr term from priority
A61B 2560/063A61B 5/1451A61B 5/0031Y02A90/10A61B 5/14546A61B 5/14514A61B 2560/0223A61M 5/14244A61B 5/6848A61B 5/14865A61B 5/14A61B 5/0002A61B 5/14532A61B 5/14507A61B 5/1495A61M 2005/1585A61B 5/150022A61B 5/72A61B 5/68335A61B 5/14735A61B 5/1468A61B 2560/045A61B 5/6849A61B 5/14503A61B 5/1411A61B 5/6801A61B 2562/18A61B 5/0004A61B 5/05A61B 5/145A61B 5/6833A61B 17/3468A61B 5/1486A61B 2017/3492A61M 5/1723A61B 5/1473A61B 5/688
81
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

Claims

exact text as granted — not AI-modified
1 - 12 . (canceled) 
     
     
         13 . A system for measuring an analyte concentration in a host, the system comprising:
 a transcutaneous analyte sensor; and   sensor electronics configured to operatively connect to the transcutaneous analyte sensor.   
     
     
         14 . A method for processing data from a transcutaneous analyte sensor, the method comprising:
 receiving sensor data indicative of an analyte concentration in the host; and   processing, using a processor, the sensor data.

Join the waitlist — get patent alerts

Track US2021290119A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.